Oxidative and nitrative stress in neurodegeneration.

The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression. Oxid Med Cell Longev (2015) 0.86

Promotion of behavior and neuronal function by reactive oxygen species in C. elegans. Nat Commun (2016) 0.82

HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Front Microbiol (2015) 0.80

The roles of macrophage autophagy in atherosclerosis. Acta Pharmacol Sin (2016) 0.79

NADPH oxidase in brain injury and neurodegenerative disorders. Mol Neurodegener (2017) 0.78

Antioxidants Attenuate Acute and Chronic Itch: Peripheral and Central Mechanisms of Oxidative Stress in Pruritus. Neurosci Bull (2016) 0.77

Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53. J Neurosci Res (2015) 0.76

Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are cardiolipin phospholipases. Genes Dev (2015) 0.76

Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases. J Neuroinflammation (2016) 0.76

Sestrin2, a Regulator of Thermogenesis and Mitohormesis in Brown Adipose Tissue. Front Endocrinol (Lausanne) (2015) 0.76

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons. PLoS One (2015) 0.76

Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy. Mol Neurobiol (2016) 0.75

GDE2 is essential for neuronal survival in the postnatal mammalian spinal cord. Mol Neurodegener (2017) 0.75

The Influence of Fluorine on the Disturbances of Homeostasis in the Central Nervous System. Biol Trace Elem Res (2016) 0.75

Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5-dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics. Mol Biol Cell (2016) 0.75

Region-Specific Defects of Respiratory Capacities in the Ndufs4(KO) Mouse Brain. PLoS One (2016) 0.75

Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism. Brain Res Bull (2017) 0.75

Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway. Redox Biol (2017) 0.75

APP processing and synaptic function. Neuron (2003) 8.37

S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science (2004) 4.97

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol (2011) 4.76

Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev (2005) 4.61

S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature (2006) 4.54

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci (2002) 4.38

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A (1998) 4.14

The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry (1999) 3.98

Parkinson's disease. Hum Mol Genet (2007) 3.84

Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev (2010) 3.69

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 2.95

Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci (2005) 2.78

Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev (2014) 2.66

Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol (2010) 2.43

Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci (2001) 2.40

Complex inhibitory effects of nitric oxide on autophagy. Mol Cell (2011) 2.36

Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci (1999) 2.25

Endogenous production of hydrogen sulfide in mammals. Amino Acids (2004) 2.18

Microglial priming in neurodegenerative disease. Nat Rev Neurol (2014) 2.04

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain (2002) 2.00

Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett (1995) 2.00

The role of nitric oxide in multiple sclerosis. Lancet Neurol (2002) 2.00

Nitro-fatty acid formation and signaling. J Biol Chem (2008) 1.95

Oxidative damage in multiple sclerosis lesions. Brain (2011) 1.95

Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem (2006) 1.90

Microglial activation in stroke: therapeutic targets. Neurotherapeutics (2010) 1.84

Oxidative stress in Huntington's disease. Brain Pathol (1999) 1.80

Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol (2007) 1.80

Nitro-fatty acid reaction with glutathione and cysteine. Kinetic analysis of thiol alkylation by a Michael addition reaction. J Biol Chem (2007) 1.78

Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure (2011) 1.74

Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem Res Toxicol (1999) 1.72

Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci U S A (1998) 1.71

Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry (2014) 1.65

Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem (2006) 1.64

Transduction of redox signaling by electrophile-protein reactions. Sci Signal (2009) 1.62

Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes (2008) 1.59

Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol (2007) 1.48

Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol. Neuroendocrinology (2013) 1.47

Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc Natl Acad Sci U S A (2006) 1.44

The relevance of animal models in multiple sclerosis research. Pathophysiology (2011) 1.40

The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem (2007) 1.37

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol (2013) 1.31

Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem (2005) 1.31

Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects. Acc Chem Res (2012) 1.28

Peroxynitrite, a stealthy biological oxidant. J Biol Chem (2013) 1.27

Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci (2005) 1.24

Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing! Age Ageing (2006) 1.24

Diabetic neuropathy. Endocrinol Metab Clin North Am (2013) 1.23

Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell (2009) 1.22

Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol (2007) 1.21

S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A (2009) 1.20

Regulation of autophagy by lysosomal positioning. Autophagy (2011) 1.19

Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell (2008) 1.19

Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia (2008) 1.18

Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med (2012) 1.18

Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience (2005) 1.18

Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann N Y Acad Sci (2006) 1.15

The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin Dev Immunol (2013) 1.14

Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Sci (2002) 1.13

Nitration of Hsp90 induces cell death. Proc Natl Acad Sci U S A (2013) 1.13

Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease. Neurodegener Dis (2012) 1.10

Neurodegeneration in diabetes mellitus. Adv Exp Med Biol (2012) 1.10

Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release. Mol Pharmacol (2004) 1.09

Conjugated linoleic acid is a preferential substrate for fatty acid nitration. J Biol Chem (2012) 1.09

Nitric oxide and lipid peroxidation. Biochim Biophys Acta (1999) 1.08

Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients. Biochem Biophys Res Commun (2007) 1.06

Inhibitors of microglial neurotoxicity: focus on natural products. Molecules (2011) 1.06

Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J Biol Chem (1996) 1.05

Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis. Brain Res (2009) 1.05

Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res (2010) 1.05

Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp Diabesity Res (2003) 1.04

Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms. ASN Neuro (2010) 1.03

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology (2004) 1.03

Protein and lipid nitration: role in redox signaling and injury. Biochim Biophys Acta (2008) 1.02

Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations. J Biol Chem (2007) 1.02

Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. Innate Immun (2013) 1.02

Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1. PLoS One (2013) 1.02

Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage. FASEB J (2005) 1.02

Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease. Mol Neurobiol (2012) 1.02

Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics. Expert Opin Biol Ther (2003) 1.01

Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. J Neurochem (2011) 1.00

Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease. Toxicol Lett (2011) 0.99

Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease. Neuroscience (2006) 0.99

Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons. Neuroscience (1998) 0.98

α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction. PLoS One (2013) 0.97

Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic Res (2008) 0.97

Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis. Mult Scler (2007) 0.97

Neuroinflammation, neurodegeneration, and depression. Neurotox Res (2012) 0.95

Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol (2010) 0.95

Olives and olive oil are sources of electrophilic fatty acid nitroalkenes. PLoS One (2014) 0.95

Coexpressed D1- and D2-like dopamine receptors antagonistically modulate acetylcholine release in Caenorhabditis elegans. Genetics (2011) 0.95

Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav Immun (2007) 0.94

Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging (2014) 0.93

Autophagy, reactive oxygen species and the fate of mammalian cells. Free Radic Res (2010) 0.93

Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice. J Neurochem (2003) 0.93

Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency. Int J Mol Med (2009) 0.91

Neuroprotective effects of resveratrol in Alzheimer disease pathology. Front Aging Neurosci (2014) 0.91

Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress. Brain Res (2010) 0.90

Resveratrol: new avenues for a natural compound in neuroprotection. Curr Pharm Des (2013) 0.90

Resveratrol protects the brain of obese mice from oxidative damage. Oxid Med Cell Longev (2013) 0.89